A Clinical study of safety and P2Y12 receptor inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese patient

Exclusion Criteria

• - History of any clinically significant disease or disorder which, in the opinion of the investigator, may either put the patient at risk because of participation in the study, or influence the results or the patient's ability to participate in the study
• - Unstable angina or any clinically significant illness, medical/surgical procedure or trauma within 4 weeks of the first administration of IP
• - Patients who had acute coronary syndrome or stent placed within 12 months of screening
• - Planned arterial revascularization
• - Current use of ADP receptor blockers (eg, clopidogrel, ticlopidine, prasugrel), dipyridamole or cilostazol